BRKR Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in bl
BRKR Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in blood Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in blood Bruker Corp - disqver acquisition not